Charles Sternberg, Associate Editor01.25.22
Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, Texas, has launched Mg Osteoinject, an injectable bone void filler which incorporates magnesium - a critical component for bone health and development, in the U.S. This flowable product is designed to promote bone repair and regeneration within insufficiency and micro fractures.
“We are excited to bring our latest innovative orthopedic technological advancement to surgeons and their patients,” said BSI president and CEO, Drew Diaz. “As the only magnesium-based bone repair product for insufficiency fractures, Mg Osteoinject provides a surgical solution that is unlike anything currently available on the market.”
Mg Osteoinject is currently being distributed to facilities and surgical centers nationwide for immediate clinical use.
“We are excited to bring our latest innovative orthopedic technological advancement to surgeons and their patients,” said BSI president and CEO, Drew Diaz. “As the only magnesium-based bone repair product for insufficiency fractures, Mg Osteoinject provides a surgical solution that is unlike anything currently available on the market.”
Magnesium as a Key Component
BSI says the efficacy of magnesium was a key component of its approach to developing the Mg Osteoinject technology. Magnesium contains high specific strength and a modulus of elasticity that closely resembles human bone. Approximately 60% of magnesium in the body resides in the bones, contributing to the structural development of bone and playing a key role in the absorption and regulation of calcium. Because of these characteristics, Mg Osteoinject is resorbable and is designed to safely assimilate back into the body during the healing process as it is replaced with bone.Mg Osteoinject is currently being distributed to facilities and surgical centers nationwide for immediate clinical use.